Jupiter Neurosciences, Inc. (JUNS) Stock Statistics & Valuation Metrics

Jupiter Neurosciences, Inc. has a market cap or net worth of $4.36M. The enterprise value is $10.82M.

Jupiter Neurosciences, Inc. has 770,081 shares outstanding. The number of shares has decreased by -2.65% in one year.

Jupiter Neurosciences, Inc.’s return on equity (ROE) is 4.72 and return on invested capital (ROIC) is -255.45%.

The current PE Ratio of Jupiter Neurosciences, Inc. is ―. Jupiter Neurosciences, Inc.’s PEG ratio is -0.02.

In the last 12 months, Jupiter Neurosciences, Inc. had revenue of 21.80K and earned -8.64M in profits. Earnings per share was -18.75.

In the last 12 months, operating cash flow was -7.25M and capital expenditures 0.00, giving a free cash flow of -7.25M billion.

Jupiter Neurosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Jupiter Neurosciences, Inc. upcoming earnings date is ―, ―.

Jupiter Neurosciences, Inc. as a current ratio of 0.65, with Debt / Equity ratio of -477.93%

In the past 12 months, Jupiter Neurosciences, Inc. has paid 0.00 in taxes.

Jupiter Neurosciences, Inc. EV to EBITDA ratio is -4.30, with an EV/FCF ratio of -6.81.

Jupiter Neurosciences, Inc. has $1.52M in cash and marketable securities with $1.75M in debt, giving a net cash position of -$227.20K billion.

Gross margin is 88.34%, with operating margin of -40873.19%, and net profit margin of -39662.77%.

The average price target for Jupiter Neurosciences, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy